International Regulation of Pharmaceuticals: A WHO International Code of Conduct for the Marketing of Pharmaceuticals?
SYRACUSE JOURNAL OF INTERNATIONAL LAW AND COMMERCE 11(1): 121-141, Summer 1984
Showing items related by title, author, creator and subject.
Guidance for Industry: M3(r2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals Unknown author (United States. Department of Health and Human Services; United States. Food and Drug Administration; Center for Biologics Evaluation and Research (U.S.); and Center for Drug Evaluation and Research (U.S.), 2010)